BioPharm International - Articles on bioprocessing methods, regulatory compliance, and biotech strategies
ASBPE

ADVERTISEMENT
Financing Innovation
Early-stage companies find alternatives to venture capital.
Author Guidelines
Previous Story Play / Pause Next Story
Video: Risk Management of Adventitious Agent Contamination in Biopharmaceutical Products
Podcast: 2012 Retrospective on Separations Technology
Podcast: Biosimilar Development
Podcast: Sutro Biopharma's Trevor Hallam offers a glimpse into the future of drug design
Podcast: Strong Product Differentiation

From the Editor
The Pathway to Publication

Compliance Notes
State of Quality and Compliance in the Biopharmaceutical Industry

Perspectives on Outsourcing
Outsourcing's Modest Role as a Cost-Containment Strategy

Burrill on Biotech
Financing Innovation

Final Word
Patents and Postapproval Batch Testing

FDA alerts health care providers of adverse reactions associated with steroid injections from Main Street Family Pharmacy in Tennessee
FDA allows marketing of first A1c test labeled for diagnosing diabetes
FDA expands alert to health care providers about lack of sterility assurance of all sterile drug products from NuVision Pharmacy
FDA seeks preliminary injunction against New York fish manufacturer
FDA approves Simponi to treat ulcerative colitis
EMD Millipore Collaborates with PharmaCell on Large-Scale, Cell-Culture Systems
May 23, 2013
SCHOTT Introduces Cartridge Design for High-Speed Filling
May 23, 2013
Moscow Hosts IFPMA Biosimilars Conference
May 17, 2013
AbbVie and Alvine Will Collaborate on Celiac Disease Therapy
May 15, 2013
FDA Issues Pharmacoepidemiologic Safety Study Guidance
May 14, 2013
Regulatory Convergence Sought for Global Pharma Market
Manufacturers work with international authorities to harmonize drug registration and supply-chain oversight.
BioPharm International - May 1, 2013
Should Regulation of Combination Products Become More Centralized in Europe?
While there are those who want combination products to be controlled by a centralized pharmaceutical-type approval system, the majority of the medical technology industry wants to retain a decentralized device-focused approach.
BioPharm International - May 1, 2013
Extractables and Leachables: Best Practices to Ensure Patient Safety
The author presents best practices for extractables and leachables.
BioPharm International - May 1, 2013
Weekly Poll
What is the most burdensome regulatory challenge facing your company?
Good manufacturing practices
Good laboratory practices
Product approval process
International regulations
Biosimilar approval process
Good manufacturing practices
50%
Good laboratory practices
0%
Product approval process
30%
International regulations
10%
Biosimilar approval process
10%
View Results
TOYOPEARL GigaCap® DEAE-650M Preserving Resolution at Increased Protein Loads
April 30, 2013
Thresholding for Accurate Detection and Measurement of Transparent Particles such as Protein Agglomerates
April 30, 2013
Liposome Characterization by FFF-MALS-QELS
April 30, 2013
Protein Separation with pH Gradients Using Composite Buffer Systems
April 30, 2013
Dual Wavelength 785 nm and 1064 nm Excitation Portable Raman Spectrometer: Rapid Authentication of Genuine and Counterfeit Pharmaceuticals
April 30, 2013
Click here